New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 17, 2014
07:08 EDTMYOSMYOS announces agreement with Cloud Pharmaceuticals
MYOS announced that it has entered into a research and development agreement with Cloud Pharmaceuticals. The research and development program will focus on product candidates related to the inhibition of targets in the myostatin regulatory pathway as well as inflammatory mediators associated with sarcopenia and cachexia. Under the terms of the agreement MYOS will have proprietary rights to the design and structure of any small molecules developed for the muscle-health treatment market.
News For MYOS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 14, 2014
10:32 EDTMYOSMYOS reports Q3 EPS (56c) vs. (20c) last year
Reports Q3 revenue $107K vs. $918K last year.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use